Chosun University Professor Chan Sik Hong's Team Reveals Activation Structure of Cold Receptor TRPM8
"Foundational Data for Structure-Based Drug Design and the Development of Next-Generation Non-Opioid Analgesics"
Chosun University announced on August 25 that a research team including Professor Chan Sik Hong from the Department of Physiology, College of Medicine, Chosun University as co–first author has unveiled the activation mechanism and operational principle of the cold receptor TRPM8, which is responsible for sensing cold in the human body.
Professor Chan-sik Hong, Department of Physiology, College of Medicine, Chosun University.
View original imageThis research was conducted jointly with the research team of Professor Hyung Ho Lee from the Department of Chemistry at Seoul National University. The paper, titled “Symmetry-driven gating of TRPM8 by PIP2 and menthol,” was published in the international scientific journal Nature Communications (IF 18.1) on July 21.
The research team combined structural analysis using cryogenic electron microscopy (cryo-EM) with electrophysiological experiments to identify, at a molecular level, the process through which TRPM8 becomes activated in response to stimuli.
TRPM8 is an ion channel that mainly responds to cold temperatures ranging from approximately 15°C to 28°C, as well as to compounds like menthol. The cool sensation experienced from mint, peppermint, toothpaste, and similar products is attributed to menthol activating TRPM8. Notably, TRPM8’s involvement in pain modulation has drawn attention to it as a primary research target for developing non-opioid analgesics.
The research team gained significant attention by identifying a previously unknown asymmetric intermediate state in which, when PIP2 binds, the four subunits that make up TRPM8 temporarily pair up in twos. During this process, the binding site structure opens to allow menthol to bind, and upon menthol binding, the structure transitions back to a symmetric tetramer, leading to channel activation. The team also discovered that menthol stabilizes the binding of PIP2.
Furthermore, by using icilin—a synthetic agonist approximately 1,000 times more potent than menthol—the team confirmed the open, active structure of TRPM8 through which ions can pass. This research concretely presented the activation process of TRPM8, from PIP2 binding, conformational changes, menthol binding, to channel opening.
Professor Chan Sik Hong in particular led the electrophysiological experiments, verifying how the structural changes delineated through analysis connect to the actual functional properties of TRPM8. He analyzed the activation characteristics of TRPM8 induced by menthol and icilin, examined the regulatory effects of PIP2 and intracellular calcium, and verified the functions of key amino acid residues, thereby functionally supporting the activation model proposed structurally.
This study is significant in that it elucidated both the structural changes and the actual functional mechanisms of the cold receptor TRPM8. The findings are expected to serve as foundational data for structure-based drug design targeting TRPM8 and for the development of next-generation non-opioid analgesics.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Chan Sik Hong stated, “The greatest significance of this study is that we were able to connect structural changes and function of TRPM8 into a cohesive mechanism,” adding, “I hope that the structural intermediate state we identified will become an important starting point in drug development research targeting TRPM8.”
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.